Circulating kallikreins in normotensive and hypertensive humans: Effects of mineralocorticoid administration

Blood Pressure

Volumn 6, Issue 4, 1997, Pages 214-222

  Öhman, K Peter ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aldosterone; Angiotensin II; Fludrocortisone; Hypertension; Pre kallikrein; Tissue kallikrein

Indexed keywords

FLUDROCORTISONE; KALLIKREIN; MINERALOCORTICOID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; HYPERTENSION; KALLIKREIN KININ SYSTEM; MALE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0030874055     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059709062072     Document Type: Article

References (18)

1. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992; 44: 1-80.
2. Margolius HS. Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease. Hypertension 1995; 26: 221-9.
3. Carretero OA, Scicli AG. Kinins paracrine hormone. Kidney Int 1988; 34: S52-S59.
4. Öhman KP, Karlberg BE. Plasma and tissue kallikrein-kinin systems during acute administration of frusemide in normotensive and hypertensive humans. Clin Sci 1991; 81: 305-11.
5. Fyhrquist F, Soveri P, Puutula L, Stenman UH. Radioimmunoassay of plasma renin activity. Clin Chem 1976; 22: 250-6.
6. Kappelgaard AM, Damkjaer-Nielsen M, Giese J. Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clin Chim Acta 1976; 67: 299-306.
7. McKenzie JK, Clements JA. Simplified radioimmunoassay for serum aldosterone utilizing increased antibody specificity. J Clin Endocrinol 1974; 38: 622-7.
8. Brown RD, Swander A, McKenzie JK. Urine aldosterone radioimmunoassay: validation of a method without chromatography. J Clin Endocrinol 1976; 42: 984-90.
9. Bagshaw AF, Bhoola KD, Lemon MJC, Whicher JT. Development and characterization of a radioimmunoassay to measure human tissue kallikrein in biological fluids. J Endocrinol 1984; 101: 173-9.
10. Friberger P, Eriksson E, Gustavsson S, Claesson G. Determination of pre-kallikrein in plasma by means of a chromogenic tripeptide substrate for plasma kalllikrein. In: Fujii S, Moriya H, Suzuki T, eds. Kinins II. Biochemistry, pathophysiology, and clinical aspects. New York: Plenum Publishing Corp., 1979: 67-82.
11. Amundsen E, Putter J, Friberger P, Knös M, Larsbraten M, Claeson G. Methods for determination of glandular kallikrein by means of chromogenic tripeptide substrate. In: Fujii S, Moriya H, Suzuki T, eds. Kinins II. Biochemistry, pathophysiology, and clinical aspects. New York: Plenum Publishing Corp., 1979: 83-95.
12. Pellacani A, Brunner HR, Nussberger J. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. Clin Sci 1994; 87: 567-74.
13. Uehara Y, Hirawa N, Kawabata Y, Suzuki T, Ohshima N, Oka K, Ikeda T, Goto A, Toyo-oka T, Kizuki K, Omata M. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Hypertension 1994; 24: 770-8.
14. Aasen OA, Frolich W, Saugstad OD, Amundsen E. Plasma kallikrein activity and pre-kallikrein levels during endotoxin shock in dogs. Eur Surg Res 1978;10: 50-62.
15. Dela Cadena RA, Suffredini AF, Page JD, Pixley RA. Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. Blood 1993; 81: 3313-7.
16. Scicli AG, Ørstavik TB, Rabito SF, Murray RD, Carretero OA. Blood kinins after sympathetic nerve stimulation of the rat submandibular gland. Hypertension 1983; 5: I101-I106.
17. Margolius HS, Geller R, Pisano JJ, Sjoerdsma A. Altered urinary kallikrein excretion in human hypertension. Lancet 1971; ii: 1063-5.
18. Blackwood AM, Inoue J, Sagnella GA, Miller MA, Markandu ND, MacGregor GA. Are the changes in urinary kallikrein excretion on altering sodium intake an index of sodium sensitivity? J Hum Hypertension 1994; 8: 619-21.